USPTO serial 88958597
BIOQ PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- DEAN, JULES J.
- Law office
- TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with BIOQ PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
NEW YORK, NY, US
San Francisco, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas W. Galvani
THOMAS W. GALVANI THOMAS W. GALVANI, P.C.3519 E. SHEA BLVD, SUITE 129PHOENIX, AZ 85028UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for treatment of medical disorders treatable by parenteral infusion therapy, namely, pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases, and metabolic diseases, and for induction and maintenance of anesthesia; Sterile preparations for medical purposes in clinical treatment for treating pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases and metabolic diseases, and for administering anesthesia; Medicinal preparations for pharmaceutical purposes for treating pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases and metabolic diseases, and for administering anesthesia; Drug delivery agents in the form of pharmaceutical infusion pumps that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations | ACTIVE | — |
| 010 | Surgical, medical, dental and veterinary apparatus and instruments for performing parenteral infusions in the field of medical and surgical procedures; Parenteral infusion pumps and dispensers; Medical infusion pumps | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 16, 2021 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 16, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 2, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 2, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 2, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 1, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 8, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 13, 2020 | NWAP | NEW APPLICATION ENTERED | — |